Shahin Jamal

Vancouver, BC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 49 publications

Canadian Rheumatology Association Living Guidelines for Rheumatoid Arthritis: Update #3.

Canadian Rheumatology Association Living Guidelines for Rheumatoid Arthritis: Update #3.

Journal: The Journal of rheumatology

Published: April 01, 2026

Canadian Rheumatology Association Living Guidelines for Rheumatoid Arthritis: Update #3.

Canadian Rheumatology Association Living Guidelines for Rheumatoid Arthritis: Update #3.

Journal: The Journal of rheumatology

Published: April 01, 2026

Validation of International Classification of Diseases (ICD) code-based case definitions of immune checkpoint inhibitor associated inflammatory arthritis from administrative health data.

Validation of International Classification of Diseases (ICD) code-based case definitions of immune checkpoint inhibitor associated inflammatory arthritis from administrative health data.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: September 23, 2025

Canadian Rheumatology Association/Canadian Research Group of Rheumatology in Immuno-Oncology Living Guidelines for Baseline Immunosuppression in Individuals With Preexisting Rheumatic Diseases Initiating Immune Checkpoint Inhibitors. Part 1: Preexisting Inflammatory Arthritides.

Canadian Rheumatology Association/Canadian Research Group of Rheumatology in Immuno-Oncology Living Guidelines for Baseline Immunosuppression in Individuals With Preexisting Rheumatic Diseases Initiating Immune Checkpoint Inhibitors. Part 1: Preexisting Inflammatory Arthritides.

Journal: The Journal of rheumatology

Published: July 28, 2025

Canadian Rheumatology Association/Canadian Research Group of Rheumatology in Immuno-Oncology Living Guidelines for Baseline Immunosuppression in Individuals With Preexisting Rheumatic Diseases Initiating Immune Checkpoint Inhibitors. Part 2: Preexisting Systemic Autoimmune Rheumatic Diseases.

Canadian Rheumatology Association/Canadian Research Group of Rheumatology in Immuno-Oncology Living Guidelines for Baseline Immunosuppression in Individuals With Preexisting Rheumatic Diseases Initiating Immune Checkpoint Inhibitors. Part 2: Preexisting Systemic Autoimmune Rheumatic Diseases.

Journal: The Journal of rheumatology

Published: July 28, 2025

Acrocyanosis After Immunotherapy: Vasculitis or Vasculopathy? New Iatrogenic Disease Case Series From CanRIO.

Acrocyanosis After Immunotherapy: Vasculitis or Vasculopathy? New Iatrogenic Disease Case Series From CanRIO.

Journal: The Journal of rheumatology

Published: April 15, 2025

Immune checkpoint inhibitors and the pediatric rheumatologist: a pediatric needs assessment.

Immune checkpoint inhibitors and the pediatric rheumatologist: a pediatric needs assessment.

Journal: Pediatric rheumatology online journal

Published: April 06, 2025

Improving Knowledge Dissemination of Rheumatic Toxicities of Cancer Immunotherapy: A Web-Based Educational Initiative.

Improving Knowledge Dissemination of Rheumatic Toxicities of Cancer Immunotherapy: A Web-Based Educational Initiative.

Journal: Musculoskeletal care

Published: January 21, 2025

Chronicity of Immune Checkpoint Inhibitor-Associated Inflammatory Arthritis After Immunotherapy Discontinuation: Results From the Canadian Research Group of Rheumatology in Immuno-Oncology Database.

Chronicity of Immune Checkpoint Inhibitor-Associated Inflammatory Arthritis After Immunotherapy Discontinuation: Results From the Canadian Research Group of Rheumatology in Immuno-Oncology Database.

Journal: ACR open rheumatology

Published: December 30, 2024

Effect of Age on Rheumatic Immune-Related Adverse Events: Experience From the Canadian Research Group of Rheumatology in Immuno-Oncology (CanRIO).

Effect of Age on Rheumatic Immune-Related Adverse Events: Experience From the Canadian Research Group of Rheumatology in Immuno-Oncology (CanRIO).

Journal: The Journal of rheumatology

Published: December 02, 2024

Canadian Rheumatology Association Living Guidelines for Rheumatoid Arthritis: Update #2.

Canadian Rheumatology Association Living Guidelines for Rheumatoid Arthritis: Update #2.

Journal: The Journal of rheumatology

Published: July 15, 2024

De novo Connective Tissue Disorders as Immune-related Adverse Events.

De novo Connective Tissue Disorders as Immune-related Adverse Events.

Journal: Rheumatic diseases clinics of North America

Published: April 26, 2024

Showing 1-12 of 49

Last Updated: 09/26/2026